Ken Reali has gained significant and varied experience in his 33-year MedTech career. He has individually contributed and then led areas including product development, global marketing, business development, commercialization, and sales of medical devices. He has a strong background in ethics and compliance, market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization. Ken has also been successful in utilizing M&A to diversify and broaden companies and has successfully led financing at both private and public companies.
As a CEO for 13 years, Reali has gained experience driving strategies to build shareholder value. He has worked with and led initiatives with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, strategic planning, and quality and lean production. He has led companies through sales processes to new ownership and into public markets through IPO.
Reali started his career at two large multi-national companies, Biomet and Stryker where he held positions of increasing responsibility. Ken then gained general management experience at Smith & Nephew starting in 2006 prior to taking on his first CEO role in 2010 at TranS1 driving a turnaround strategy. Reali then led Clinical Innovations, a women’s healthcare company through successful exit after five years while doubling the business size and value. In 2020 he led Bioventus through an IPO while increasing the size of the business by 80% through strategic M&A.
Ken Reali serves on the board of directors of a broad group of companies in MedTech from orthopedics to women’s healthcare. Reali also donates his time serving on the board of directors of AdvaMed, the National Italian American Foundation, and Valparaiso University College of Business. Ken lives in Walla Walla, Washington with his wife Kristin where they started a vineyard several years ago.